Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-45.62	7.29	13.41
Graham Fair Price	41.42	2.17	1.53
PEG	-48.98	0.01	-0.02
Price/Book	-9.53	0.15	0.17
Price/Cash Flow	54.76	-26.60	-58.81
Prices/Earnings	-54.76	1.14	2.51
Price/Sales	-54.76	0.30	0.67
Price/FCF	54.76	-26.60	-58.81
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.14	0.14
Operating Margin	72.39	-0.01	< 0.005
ROA	100.00	0.02	< 0.005
ROE	0.02	0.03	100.00
ROIC	< 0.005	< 0.005	246.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.03	-0.13	79.97
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.02	-4.45	336.34
EPS QOQ	1.13	1.00	-11.34
FCF QOQ	-1.10	-1.00	9.50
Revenue QOQ	-0.46	1.00	116.88
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	163.27	81.63	-50.00
Days Sales Outstanding (DSO)	80.79	41.29	-48.89
Inventory Turnover	0.55	1.10	100.00
Debt/Capitalization	0.22	0.22	-2.02
Quick Ratio	0.55	0.57	4.36
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	2.50	2.50	< 0.005
Cash	0.42	0.45	7.27
Capex	< 0.005	-0.01	-100.00
Free Cash Flow	< 0.005	-0.01	-100.00
Revenue	0.63	1.26	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.36	1.36	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.57	3.67	-44.16
Naive Interpretation	Member

06 - Financial Health · Weak

Rating